Technology
Health
Medical

Electromed

$5.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (2.01%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Electromed and other stocks, options, ETFs, and crypto commission-free!

About

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. It offers smartvest, and airways clearance system to patients with compromised pulmonary function. Read More It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

Employees
132
Headquarters
New Prague, Minnesota
Founded
1992
Market Cap
46.92M
Price-Earnings Ratio
24.04
Dividend Yield
0.00
Average Volume
19.63K
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$7.33
52 Week Low
$4.60

Collections

Technology
Health
Medical
Advertising and Marketing
Medical Devices
Business Services
US
North America

News

Seeking AlphaMay 11

Electromed, Inc. CEO Kathleen Skarvan on Q3 2019 Results - Earnings Call Transcript

Electromed, Inc. (NYSEMKT:ELMD) Q3 2019 Earnings Conference Call May 8, 2019 9:00 AM ET Company Participants Kalle Ahl - Senior Associate, The Equity Group, IR Kathleen Skarvan - President and CEO Jeremy Brock - CFO Conference Call Participants Kyle Bauser - Dougherty & Company Tim Chatard - Quantum Capital Operator Greetings, and welcome to Electromed's Third Quarter Fiscal 2019 Financial Results Conference Call. At this time all participants are in a listen-only mode. A brief question and answer ...

2
Yahoo FinanceMay 7

Electromed, Inc. Announces Fiscal 2019 Third Quarter Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2019 (Q3 FY 2019). Q3 FY 2019 Highlights Net revenue increased 3.4% to $7.4 million from $7.2 million during the three months ended March 31, 2018 (Q3 FY 2018). Net revenue, gross profit and operating income in Q3 FY 2019 were negatively impacted by a lower average selling price based on payor mix as comp...

5
Simply Wall StMay 2

Do You Know About Electromed, Inc.’s (NYSEMKT:ELMD) ROCE?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we are going to look at Electromed, Inc. (NYSEMKT:ELMD) to see whether it might be an attractive investment prospect. Specifically, we’re going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. First of all, we’ll work out how to calculate ROCE. Then we’ll compare its ROCE to similar companies. Then we’ll determine how i...

8

Earnings

$0.00
$0.04
$0.09
$0.13
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
$0.04 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.